These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 987908)

  • 21. [HEMOLYTIC DISEASE OF THE NEWBORN INFANT CAUSED BY ABO INCOMPATIBILITY, DIAGNOSTIC VALUE OF THE BIOLOGICAL TESTS IN THE INFANT].
    GUIMBRETIERE J; TOSCER M
    Transfusion (Paris); 1964; 7():191-201. PubMed ID: 14168284
    [No Abstract]   [Full Text] [Related]  

  • 22. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 24. D-penicillamine therapy of neonatal jaundice: comparison with phototherapy.
    Lakatos L; Kövér B; Vekerdy S; Dvorácsek E
    Acta Paediatr Acad Sci Hung; 1976; 17(2):93-102. PubMed ID: 1036444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABO hemolytic disease: a comparative study of clinical severity and delayed anemia.
    Kanto WP; Marino B; Godwin AS; Bunyapen C
    Pediatrics; 1978 Sep; 62(3):365-9. PubMed ID: 568235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Icterus gravis in ABO incompatibility and bilirubin coupling disorders].
    Stur O
    Wien Med Wochenschr; 1970 May; 120(22):400-1. PubMed ID: 5534805
    [No Abstract]   [Full Text] [Related]  

  • 27. [HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ABO ISOIMMUNIZATION. DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS].
    LANGE MM; DICAGNO L; CASTELLO D
    Minerva Pediatr; 1964 Jan; 16():34-43. PubMed ID: 14137806
    [No Abstract]   [Full Text] [Related]  

  • 28. The spectrum of ABO hemolytic disease of the newborn infant.
    Desjardins L; Blajchman MA; Chintu C; Gent M; Zipursky A
    J Pediatr; 1979 Sep; 95(3):447-9. PubMed ID: 469673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of ABO hemolytic disease with synthetic blood group trisaccharides.
    Romano EL; Soyano A; Montaño RF; Ratcliffe M; Olson M; Suarez G; Martínez N; Worsley G
    Vox Sang; 1994; 66(3):194-9. PubMed ID: 8036789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ABO INCOMPATIBILITY: A STUDY OF THE USE OF GROUP O ERYTHROCYTES IN AB PLASMA.
    GOLDARB DL; GINSBERG V; KAUFMAN M; ROBINSON MG; WATSON RJ
    Pediatrics; 1964 Nov; 34():664-9. PubMed ID: 14227646
    [No Abstract]   [Full Text] [Related]  

  • 31. D-penicillamine treatment of hyperbilirubinaemia in preterm infants.
    Korányi G; Kovács J; Vörös I
    Acta Paediatr Acad Sci Hung; 1978; 19(1):9-16. PubMed ID: 665227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial difference in incidence of ABO hemolytic disease.
    Bucher KA; Patterson AM; Elston RC; Jones CA; Kirkman HN
    Am J Public Health; 1976 Sep; 66(9):854-8. PubMed ID: 961953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
    Yogev-Lifshitz M; Leibovitch L; Schushan-Eisen I; Taran C; Strauss T; Maayan-Metzger A
    Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mortality of newborn infants with hemolytic disease treated by exchange transfusion. Analysis of 524 cases].
    Polácek K
    Cesk Pediatr; 1967 Dec; 22(12):1059-66. PubMed ID: 4965949
    [No Abstract]   [Full Text] [Related]  

  • 36. [Our experience with the pre- and postnatal diagnosis of ABO-hemolytic disease of the newborn].
    Novachev D; Markov L; Antonov L; Tankov Ts
    Akush Ginekol (Sofiia); 1977; 16(5):317-26. PubMed ID: 413455
    [No Abstract]   [Full Text] [Related]  

  • 37. [TREATMENT OF HEMOLYTIC DISEASE OF THE NEWBORN].
    LARDINOIS R
    Rev Med Liege; 1963 Oct; 18():648-53. PubMed ID: 14097936
    [No Abstract]   [Full Text] [Related]  

  • 38. D-Penicillamine administration and the incidence of retinopathy of prematurity.
    Christensen RD; Alder SC; Richards SC; Lambert DK; Schmutz N; Wiedmeier SE; Burnett J; Baer VL; Horn JT; Richards M; Barraza J
    J Perinatol; 2007 Feb; 27(2):103-11. PubMed ID: 17262043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
    Hodr R; Vondrácek J; Skutilová J
    Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum bilirubin level in full-term and premature infants after exchange transfusions.
    Rosta J; Wohlmuth G
    Acta Paediatr Acad Sci Hung; 1966; 7(2):183-93. PubMed ID: 5951017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.